Denali Therapeutics Stock Market Value
| DNLI Stock | USD 15.56 0.55 3.41% |
| Symbol | Denali |
Denali Therapeutics Price To Book Ratio
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.06) | Revenue Per Share 2.406 | Quarterly Revenue Growth (1.00) | Return On Assets (0.09) | Return On Equity (0.14) |
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Denali Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Denali Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Denali Therapeutics.
| 03/25/2024 |
| 04/24/2024 |
If you would invest 0.00 in Denali Therapeutics on March 25, 2024 and sell it all today you would earn a total of 0.00 from holding Denali Therapeutics or generate 0.0% return on investment in Denali Therapeutics over 30 days. Denali Therapeutics is related to or competes with Stoke Therapeutics, Black Diamond, 4D Molecular, Ascendis Pharma, Apellis Pharmaceuticals, BeiGene, and Akero Therapeutics. Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerati... More
Denali Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Denali Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Denali Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.28 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 51.7 | |||
| Value At Risk | (6.57) | |||
| Potential Upside | 4.94 |
Denali Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Denali Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Denali Therapeutics' standard deviation. In reality, there are many statistical measures that can use Denali Therapeutics historical prices to predict the future Denali Therapeutics' volatility.| Risk Adjusted Performance | 0.0156 | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.76) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0157 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Denali Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Denali Therapeutics Backtested Returns
We consider Denali Therapeutics somewhat reliable. Denali Therapeutics secures Sharpe Ratio (or Efficiency) of 3.0E-4, which denotes the company had a 3.0E-4% return per unit of risk over the last 3 months. We have found thirty technical indicators for Denali Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Denali Therapeutics' Coefficient Of Variation of 9305.82, downside deviation of 4.28, and Mean Deviation of 3.19 to check if the risk estimate we provide is consistent with the expected return of 0.0021%. The firm shows a Beta (market volatility) of 3.42, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Denali Therapeutics will likely underperform. Denali Therapeutics right now shows a risk of 6.08%. Please confirm Denali Therapeutics sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Denali Therapeutics will be following its price patterns.
Auto-correlation | 0.76 |
Good predictability
Denali Therapeutics has good predictability. Overlapping area represents the amount of predictability between Denali Therapeutics time series from 25th of March 2024 to 9th of April 2024 and 9th of April 2024 to 24th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Denali Therapeutics price movement. The serial correlation of 0.76 indicates that around 76.0% of current Denali Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 1.44 |
Denali Therapeutics lagged returns against current returns
Autocorrelation, which is Denali Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Denali Therapeutics' stock expected returns. We can calculate the autocorrelation of Denali Therapeutics returns to help us make a trade decision. For example, suppose you find that Denali Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Denali Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Denali Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Denali Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Denali Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Denali Therapeutics Lagged Returns
When evaluating Denali Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Denali Therapeutics stock have on its future price. Denali Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Denali Therapeutics autocorrelation shows the relationship between Denali Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Denali Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Denali Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Denali Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Denali Stock
| 0.75 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.68 | ELEV | Elevation Oncology Earnings Call Next Week | PairCorr |
| 0.64 | ENVB | Enveric Biosciences Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Denali Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Denali Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Denali Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Denali Therapeutics to buy it.
The correlation of Denali Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Denali Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Denali Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Denali Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Denali Therapeutics Correlation, Denali Therapeutics Volatility and Denali Therapeutics Alpha and Beta module to complement your research on Denali Therapeutics. For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Denali Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.